BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16877496)

  • 61. Composite measures for hospital quality using quality-adjusted life years.
    Timbie JW; Shahian DM; Newhouse JP; Rosenthal MB; Normand SL
    Stat Med; 2009 Apr; 28(8):1238-54. PubMed ID: 19184974
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multiple augmentation for interval-censored data with measurement error.
    Song X; Ma S
    Stat Med; 2008 Jul; 27(16):3178-90. PubMed ID: 18040984
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficient estimation of the distribution of quality-adjusted survival time.
    Zhao H; Tsiatis AA
    Biometrics; 1999 Dec; 55(4):1101-7. PubMed ID: 11315054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nonparametric estimation of the concordance correlation coefficient under univariate censoring.
    Guo Y; Manatunga AK
    Biometrics; 2007 Mar; 63(1):164-72. PubMed ID: 17447941
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analyses of cumulative incidence functions via non-parametric multiple imputation.
    Ruan PK; Gray RJ
    Stat Med; 2008 Nov; 27(27):5709-24. PubMed ID: 18712779
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
    Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
    Med Care; 2008 Sep; 46(9):946-53. PubMed ID: 18725849
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A simple local sensitivity analysis tool for nonignorable coarsening: application to dependent censoring.
    Zhang J; Heitjan DF
    Biometrics; 2006 Dec; 62(4):1260-8. PubMed ID: 17156301
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Robust best linear weighted estimator with missing covariates in survival analysis.
    Wang CY; Hsu L; Harrison T
    Stat Med; 2024 Apr; 43(9):1790-1803. PubMed ID: 38402690
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Path consistent model selection in additive risk model via Lasso.
    Leng C; Ma S
    Stat Med; 2007 Sep; 26(20):3753-70. PubMed ID: 17309043
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efron-type measures of prediction error for survival analysis.
    Gerds TA; Schumacher M
    Biometrics; 2007 Dec; 63(4):1283-7. PubMed ID: 17651459
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Statistical methods for efficiency adjusted real-time PCR quantification.
    Yuan JS; Wang D; Stewart CN
    Biotechnol J; 2008 Jan; 3(1):112-23. PubMed ID: 18074404
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Using capture-recapture models to estimate transition rates between states in interval-censored data].
    Viallefont A; Auget JL
    Rev Epidemiol Sante Publique; 1999 Dec; 47(6):627-34. PubMed ID: 10673597
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nonparametric estimation of stage occupation probabilities in a multistage model with current status data.
    Datta S; Sundaram R
    Biometrics; 2006 Sep; 62(3):829-37. PubMed ID: 16984326
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Estimating regression models with unknown break-points.
    Muggeo VM
    Stat Med; 2003 Oct; 22(19):3055-71. PubMed ID: 12973787
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increasing efficiency from censored survival data by using random effects to model longitudinal covariates.
    Hogan JW; Laird NM
    Stat Methods Med Res; 1998 Mar; 7(1):28-48. PubMed ID: 9533260
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Estimating episode lengths when some observations are probably censored.
    Goodman AC; Peng Y; Hankin JR; Kalist DE; Spurr SJ
    Stat Med; 2004 Jul; 23(13):2071-87. PubMed ID: 15211604
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Estimating the cumulative mean function for history process with time-dependent covariates and censoring mechanism.
    Deng D
    Stat Med; 2016 Nov; 35(25):4624-4636. PubMed ID: 27222200
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tobit regression for modeling mean survival time using data subject to multiple sources of censoring.
    Gong Q; Schaubel DE
    Pharm Stat; 2018 Mar; 17(2):117-125. PubMed ID: 29359427
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Understanding Cox's regression model.
    Gill R
    Experientia Suppl; 1982; 41():187-99. PubMed ID: 6754425
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tail.
    Gong Q; Fang L
    Pharm Stat; 2012; 11(2):135-40. PubMed ID: 22323424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.